Peptone supplementation to increase productivity and reduce serum use in vaccine manufacturing

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Peptone supplementation to increase productivity and reduce serum use in vaccine manufacturing

In this webinar, you will learn how animal-origin-free peptone supplementation can boost productivity and reduce serum dependence of vaccine production in mammalian cells. Data will be presented showing up to 80% reduction in serum use and 5–10-fold increase in viral titers and cell growth when producing vesicular stomatitis virus (VSV) in Vero and BHK-21 cell culture, respectively. By reducing serum dependency, manufacturers can achieve substantial cost savings.

The session will provide practical guidance on integrating peptones into your workflow. Whether you're looking to reduce costs, improve yields, or stabilize your upstream processes, the insights shared will be immediately applicable to your work.

Join the webinar to learn more about:

Evidence-backed strategies for reducing serum dependency
Comparative performance data across peptone blends and cell lines
Real-world examples of improved virus production and cell viability
Insights into adapting cells for optimal growth in peptone-supplemented media

Syed Muaz Khalil

Staff Scientist, Research & Development at Thermo Fisher Scientific

Syed Muaz Khalil is a R&D Staff Scientist at Thermo Fisher Scientific since 2020. Muaz holds a doctoral degree in Microbiology and Immunology from the University of North Carolina at Chapel Hill with a focus on viral vaccine development. At Thermo Fisher Scientific, Muaz leads a team of R&D scientists in the upstream development of media, feeds, and supplements for viral vaccine manufacturing. Muaz and team have also generated extensive application data demonstrating benefits of peptones in vaccine manufacturing.

Chris Titensor

Senior Product Manager, AOF Peptones at Thermo Fisher Scientific

Chris Titensor is a Senior Product Manager at Thermo Fisher Scientific. He has been with Thermo Fisher since 2018, serving in roles across finance, strategy, marketing, and product management. Chris holds a bachelor’s degree in finance and economics. At Thermo Fisher Scientific, Chris leads the global product strategy for animal-origin-free (AOF) peptones. His work focuses on expanding access to regulatory-aligned raw materials that enable scalable and consistent upstream bioprocessing. Chris partners closely with R&D and commercial teams to translate customer needs into innovative product solutions and to drive broader adoption of AOF peptones across biologics, cell therapies, and vaccine manufacturing.

You have registered for this webinar